SRSunil Kumar Rai

Sunil Kumar Rai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sunil Kumar Rai has a total of 60 co-authors. Here are the top co-authors by number of shared publications:

  • Ashwini Nangia

    School of Chemistry, University of Hyderabad, Prof. C. R. Rao Road, Gachibowli, Central University P.O., Hyderabad 500 046, India

    10 shared publications
  • Ashish Kumar Tewari

    Department of Chemistry (Center of Advanced Study) Institute of Science Banaras Hindu University Varanasi 221005 India

    9 shared publications
  • Shaziya Khanam

    Department of Chemistry (Center of Advanced Study) Institute of Science Banaras Hindu University Varanasi 221005 India

    7 shared publications
  • Anilkumar Gunnam

    School of Chemistry, University of Hyderabad, Prof. C. R. Rao Road, Hyderabad 500 046, India

    4 shared publications
  • Ranjana S. Khanna

    Department of Chemistry (Center of Advanced Study), Institute of Science, Banaras Hindu University, Varanasi-221005, India

    4 shared publications
  • Gaetano Marverti

    Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy

    3 shared publications

Latest Publications

  • Salt and Cocrystal Forms of Diclofenac with Pyridine and Pyridone Coformers for Improving Drug Bioavailability

    by Ankima Yadav, Madhu Rana, Pallavi Shukla, Ashwini K. Nangia, Sunil K. Rai

    The modification of the physicochemical properties of diclofenac (DCF), a Biopharmaceutics Classification System (BCS) class II drug, remains a primary objective in pharmaceutical crystal engineering. This study examines the supramolecular landscapes of DCF solid-state forms crystallized using 2-aminopyridine (2APY), 3-aminopyridine (3APY), 4-aminopyridine (4APY), 2-pyridone (2PY), 3-hydroxypyridine (3HPY), and 4-pyridone (4PY). The crystalline binary solids were characterized using single-crystal X-ray diffraction (SC-XRD) analysis. The salt, cocrystal, and continuum states were analyzed based on ΔpKa values and the difference between the carbonyl bond distances (ΔDCO) of the carboxylic acid group in DCF. It was observed that DCF·2APY and DCF·3APY cocrystallized in Z″ = 3, where the asymmetric unit contains one neutral DCF, an anionic DCF, and a cationic 2APY or 3APY molecule (Z″ is the number of distinct molecules in the asymmetric unit). DCF·4APY formed monohydrate and hemihydrate salts. DCF·2PY and DCF·4PY formed a cocrystal in a 1:1 stoichiometry of DCF and the coformer. DCF·3HPY showed a borderline case of salt and continuum states by X-ray diffraction and based on ΔDCO and ΔpKa difference values. The thermodynamic properties of the structurally characterized solid forms were evaluated by differential scanning calorimetry (DSC) and thermogravimetric analysis (TGA). Solubility and dissolution analysis furnished the stability of DCF·2APY (1:1) in acidic and neutral media and showed an enhancement in the equilibrium solubility of ∼23-fold and ∼28-fold, respectively. However, DCF·2APY (2:1) was unstable in an acidic environment but stable in a neutral medium with an improved equilibrium solubility of ∼32-fold. Dissolution and permeability under a pH 7 buffer showed significant improvement compared to DCF free acid, where the permeability order of different solid forms was observed in the order of their dissolution rate. The highest dissolution rate and permeability/flux were observed for DCF·2APY (2:1), whereas cocrystals (DCF·2PY and DCF·4PY) showed the lowest dissolution rate and flux but still higher than that of DCF free acid. These experiments demonstrate the advantage of DCF cocrystals and salts with APY, HPY, and PY coformers over DCF free acid in terms of dissolution rate and passive permeability/flux. Furthermore, DCF·2APY (2:1), with the highest dissolution rate and flux along with 66.6% DCF and 33.3% excipient in a single crystalline phase, suggests the possibility of high-payload cocrystal engineering of DCF with 2APY.

  • Open Access

    Structure of entinostat Form B, C21H20N4O3, derived using laboratory powder diffraction data and density functional techniques

    by James A. Kaduk, Sunil Kumar Rai

    The crystal structure of entinostat Form B, C21H20N4O3, has been solved and refined using laboratory X-ray powder diffraction data, and optimized using density functional techniques. Entinostat crystallizes in space group Pna21 and the crystal structure consists of interlocking layers of entinostat molecules parallel to the bc plane. A strong N—H...N hydrogen bond links the molecules into zigzag chains propagating along the b-axis direction. The graph set for this pattern is C 1 1(8). Two N—H...O hydrogen bonds link the molecules along the c-axis direction. The graph sets for this pattern are C 1 1(4) and C 1 1(7).

  • Investigation of Permeability Trend in Primary Alkyl Ammonium Salts of Diclofenac

    by Pallavi Shukla, Anilkumar Gunnam, Ankima Yadav, Madhu Rana, Ashwini K. Nangia, Sunil K. Rai


  • Probing Short-Range Interactions in Isostructural Hydrate and Perhydrate of Dabrafenib by Magic-Angle Spinning Solid-State NMR

    by Sunil K. Rai, Lokeswara Rao Potnuru, Nghia Tuan Duong, Toshio Yamazaki, Ashwini K. Nangia, Yusuke Nishiyama, Vipin Agarwal

    Dabrafenib (DBF), an anticancer drug, exhibits isostructural properties in its hydrate (DBF⊃H2O) and perhydrate (DBF⊃H2O2) forms, as revealed by single-crystal X-ray diffraction. Despite the H2O and H2O2 solvent molecules occupying identical locations, the two polymorphs have different thermal behaviors. In general, determination of stoichiometry of H2O in the perhydrate crystals is difficult due to the presence of both H2O and H2O2 in the same crystal voids. This study utilizes magic-angle spinning (MAS) solid-state NMR (SSNMR) combined with gauge-included projector augmented wave calculations to characterize the influence of solvent molecules on the local environment in pseudopolymorphs. SSNMR experiments were employed to assign 1H, 13C, and 15N peaks and identify spectral differences in the isostructural pseudopolymorphs. Proton spectroscopy at fast MAS was used to identify and quantify H2O2/H2O in DBF⊃H2O2 (mixed hydrate/perhydrate). 1H-1H dipolar-coupling-based experiments were recruited to confirm the 3D molecular packing of solvent molecules in DBF⊃H2O and DBF⊃H2O2. Homonuclear (1H-1H) and heteronuclear (1H-14N) distance measurements, in conjunction with diffraction structures and optimized hydrogen atom positions by density functional theory, helped decipher local interactions of H2O2 with DBF and their geometry in DBF⊃H2O2. This integrated X-ray structure, quantum chemical calculations, and NMR study of pseudopolymorphs offer a practical approach to scrutinizing crystallized solvent interactions in the crystal lattice even without high-resolution crystal structures or artificial sample enrichment.


  • Cocrystallization of multi-kinase inhibitor pazopanib with fenamic acids: improving dissolution and inhibiting cell migration

    by Sunil K. Rai, Anilkumar Gunnam, Debopriya Roy, Raveena Rajput, Kiran Kulkarni, Ashwini K. Nangia

    A multi-kinase inhibitor, pazopanib (PAZ) is cocrystallized with cyclooxygenase (COX) inhibitor fenamic acids to investigate the dissolution rate and inhibition of cell migration in VEGF-triggered HUVEC cells to test the efficacy of stoichiometric drug–drug combinations. Crystallization experiments at the sub-milligram level in an acetonitrile–methanol mixture yielded two drug–drug salt forms of PAZ with flufenamic acid (FFA) and niflumic acid (NFA) as PAZ+·FFA−·ACN (an acetonitrile solvate named as form I) and PAZ+·NFA−. Structures of the crystal forms were characterized by single crystal X-ray diffraction (SC-XRD) method. Crystal structures revealed that the presence of a 2-aminopyrimidine group in PAZ is a strong partner for the carboxyl group in all solid forms, forming an acid⋯pyrimidine heterosynthon with COX inhibitor fenamic acids. To perform dissolution experiments and cell line analysis, the scale-up of both salt forms were done in the acetonitrile–methanol mixture through crystallization, which showed a polymorphic transformation in the case of PAZ+·FFA−·ACN (an acetonitrile solvate named form II). The thermodynamic stability of PAZ+·FFA−·ACN (form II) and PAZ+·NFA− were analysed using slurry experiment under ambient conditions in pH 1.2 (0.1 N HCl) buffer medium and the residual solid phase was characterized by powder XRD, which showed that PAZ+·FFA−·ACN (form II) was a metastable solid form while PAZ+·NFA− was a stable solid form. The dissolution experiments at gastric pH 1.2 showed that the rate of dissolution of PAZ+·FFA−·ACN was 10 times higher than PAZ+·NFA−. The cell migration assay suggested that PAZ+·FFA−·ACN inhibited ∼25% and PAZ+·NFA− inhibited ∼20% migration of HUVEC cells compared to PAZ alone. These investigations suggested that the drug–drug salts PAZ+·FFA− and PAZ+·NFA− would be potential combo drug candidates for clinical trials.


  • Open Access

    Dabrafenib–Panobinostat Salt: Improving the Dissolution Rate and Inhibition of BRAF Melanoma Cells

    by Sunil K. Rai, Gaetano Marverti, Anilkumar Gunnam, Suryanarayana Allu, Ashwini K. Nangia

    Cocrystallization of the drug–drug salt-cocrystal of the histone deacetylase inhibitor (HDACi) panobinostat (PAN) and b-rapidly accelerated fibrosarcoma (BRAF) inhibitor dabrafenib (DBF) afforded single crystals of a two-drug salt stabilized by N+–H···O and N+–H···N– hydrogen bonds between the ionized panobinostat ammonium donor and dabrafenib sulfonamide anion acceptor in a 12-member ring motif. A faster dissolution rate for both drugs was achieved through the salt combination compared to the individual drugs in an aqueous acidic medium. The dissolution rate exhibited a peak concentration (Cmax) of approximately 310 mg cm–2 min–1 for PAN and 240 mg cm–2 min–1 for DBF at a Tmax of less than 20 min under gastric pH 1.2 (0.1 N HCl) compared to the pure drug dissolution values of 10 and 80 mg cm–2 min–1, respectively. The novel and fast-dissolving salt DBF–·PAN+ was analyzed in BRAFV600E melanoma cells Sk-Mel28. DBF–·PAN+ reduced the dose–response from micromolar to nanomolar concentrations and lowered IC50 (21.9 ± 7.2 nM) by half compared to PAN alone (45.3 ± 12.0 nM). The enhanced dissolution and lower survival rate of melanoma cells show the potential of novel DBF–·PAN+ salt in clinical evaluation.


  • Polymorph II of hydroxyurea 150 years after its first synthesis

    by Sunil K. Rai, Srinu Tothadi, Mihails Arhangelskis, Christy P. George, Rajesh G. Gonnade, Ashwini K. Nangia

    Form II of hydroxyurea (HU) has been crystallized in the presence of urea in methanol solvent. The isoenergetic novel form II is isolated 150 years after its first synthesis (form I).


  • Polymorphs, Solvatomorphs, Hydrate, and Perhydrate of Dabrafenib

    by Sunil K. Rai, Anilkumar Gunnam, Gregory J. O. Beran, James A. Kaduk, Ashwini K. Nangia


  • Entacapone Polymorphs: Crystal Structures, Dissolution, Permeability, and Stability

    by Manish Kumar Bommaka, M. K. Chaitanya Mannava, Sunil K. Rai, Kuthuru Suresh, Ashwini K. Nangia


  • Salts, solvates and hydrates of the multi-kinase inhibitor drug pazopanib with hydroxybenzoic acids

    by Sunil K. Rai, Debjani Baidya, Ashwini K. Nangia

    The marketed formulation of pazopanib (PAZ) suffers from low and variable bioavailability because of its poor dissolution rate and photostability issues. The drug falls under Biopharmaceutics Classification System (BCS) class II of low solubility and good permeability. The hydrogen bonds and supramolecular interactions in crystalline forms of PAZ with hydroxybenzoic acids (HBAs) and dihydroxybenzoic acids (DHBAs), as well as its salts are analyzed. Ten X-ray crystal structures of PAZ which include the reference drug, a tetrahydrofuran solvate (PAZ·THF) and eight salts with HBAs/DHBAs are reported. There is proton transfer from the carboxylic group of the coformer acid to the most basic nitrogen atom of the 2-aminopyrimidine ring of PAZ in all cases. Two salts were crystallized in neat form, while the remaining six are solvates and hydrates. The crystal structure of PAZ is stabilized by sulfonamide and 2-aminopyrimidine homosynthons of N–H⋯O and N–H⋯N hydrogen bonds in an R2 2(8) ring motif. PAZ·HBA/DHBA salts consistently contain the aminopyridinium⋯carboxylate N+–H⋯O− synthon of the R2 2(8) ring. The sulfonamide homosynthon of PAZ is disrupted in preference to the formation of N–H⋯O and N–H⋯N hydrogen bonds in salt structures. The presence of an additional basic nitrogen atom in the indazole ring of PAZ promotes hydration and solvation through the O–H⋯N hydrogen bond. Whereas the formation of salts is desirable for pharmaceutical formulation, the inclusion of adventitious solvent and/or water molecules with hydroxybenzoic acid coformers in the cocrystal-salt products is a limitation for this class of coformers. The stability problem faced with hydrates and solvates of PAZ·HBA/DHBA salts means that their formation must be carried out by strictly anhydrous procedures. The consistent occurrence of the aminopyridinium⋯carboxylate N+–H⋯O− ring synthon is discussed in relation to the previous results of Aakeröy, Nangia and Zaworotko groups on similar acid–base multi-component systems.